IRGQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.245000E-01
Normal-vs-Stage2
8.335000E-01
Normal-vs-Stage3
3.398000E-01
Normal-vs-Stage4
6.772200E-01
Stage1-vs-Stage2
2.963600E-01
Stage1-vs-Stage3
2.262800E-01
Stage1-vs-Stage4
9.779800E-01
Stage2-vs-Stage3
2.436200E-01
Stage2-vs-Stage4
3.602800E-01
Stage3-vs-Stage4
2.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.507200E-01
Normal-vs-AfricanAmerican
6.222000E-01
Normal-vs-Asian
9.822000E-01
Caucasian-vs-AfricanAmerican
2.219800E-01
Caucasian-vs-Asian
8.157800E-01
AfricanAmerican-vs-Asian
5.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.263600E-01
Normal-vs-Female
9.713200E-01
Male-vs-Female
6.268800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.918000E-01
Normal-vs-Age(41-60Yrs)
6.926800E-01
Normal-vs-Age(61-80Yrs)
9.132800E-01
Normal-vs-Age(81-100Yrs)
1.559590E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.126200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.569600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.769410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.836200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.626100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.722040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.287800E-01
Normal-vs-Daily Drinker
9.839000E-01
Normal-vs-Weekly Drinker
6.771000E-01
Normal-vs-Occasional Drinker
6.494200E-01
Normal-vs-Social Drinker
9.217000E-01
Non Drinker-vs-Daily Drinker
4.828400E-01
Non Drinker-vs-Weekly Drinker
2.018600E-01
Non Drinker-vs-Occasional Drinker
9.922200E-02
Non Drinker-vs-Social Drinker
4.074600E-01
Daily Drinker-vs-Weekly Drinker
5.335000E-01
Daily Drinker-vs-Occasional Drinker
3.082600E-01
Daily Drinker-vs-Social Drinker
8.195000E-01
Weekly Drinker-vs-Occasional Drinker
5.993000E-01
Weekly Drinker-vs-Social Drinker
7.544200E-01
Occasional Drinker-vs-Social Drinker
4.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.220800E-01
Normal-vs-Grade 2
1.903610E-01
Normal-vs-Grade 3
2.068000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.441800E-01
Grade 1-vs-Grade 3
2.457200E-01
Grade 1-vs-Grade 4
3.220800E-01
Grade 2-vs-Grade 3
9.375000E-01
Grade 2-vs-Grade 4
1.903610E-01
Grade 3-vs-Grade 4
2.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.189200E-01
Normal-vs-NonDiabetic
8.472000E-01
Diabetic-vs-NonDiabetic
1.094070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.367400E-01
Normal-vs-NoPancreatitis
9.526200E-01
Pancreatitis-vs-NoPancreatitis
1.171580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.907600E-01
Normal-vs-N1
7.665000E-01
N0-vs-N1
2.810300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.880800E-01
Normal-vs-TP53-NonMutant
9.740200E-01
TP53-Mutant-vs-TP53-NonMutant
5.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
